The Marketing mix of Glenmark analyses the 4Ps of Glenmark, which includes the Product, Price, Place, and Promotion of Glenmark. Glenmark Pharmaceuticals Limited is a public company of Indian origins. It is associated with the pharmaceutical industry and deals in the research and development of specialty products. It was founded in 1977 by its founder, Gracias Saldanha. It faces competition from the following companies-
- GlaxoSmithKline
- Cipla
- Lupin
- Dr Reddy’s Lab
- Sun Pharma
About Glenmark
- Type: Pharmaceutical company
- Industry: Healthcare
- Founded: 1976
- Founder: K. M. Bangur
- Headquarters: Mumbai, India
- Area served: Over 100 countries
- Key people: Glenn Saldanha (Chairman) and Milind Deora (CEO)
- Number of employees: 13,000
Table of Contents
Glenmark Product Strategy
Glenmark Pharmaceuticals is a global entity discovering and developing novel chemical and biological entities called NCEs and NBEs, respectively. It has put its focus on the development and marketing of generic and branded formulations.
Glenmark has seven molecules in pre-clinical and clinical stages under its belt. Its portfolio includes eighty-three products with authorization for the United States market. It has launched new products in the haircare and skincare segment of the consumer market. Several over-the-counter vaccines and medicines are available because of Glenmark’s efforts.
The company has three business units and these include-
- Drug Discovery – Glenmark Pharmaceuticals is a true leader in this segment, focusing on drug discovery for arthritis and asthma in inflammation, obesity and diabetes in metabolic disorders, and neuropathic and inflammatory in the pain segment
- Formulation Business – Glenmark manufactures products in the therapeutic fields of oncology, diabetes, gynecology, cardiac, respiratory, and dermatology
- Glenmark Generics – It is a subsidiary of its parent company, Glenmark Pharmaceuticals, and puts its onus on modified products, oncology, hormones, and dermatology.
The product mix of Glenmark in 2023 is as follows(Source)
- Dermatology: Glenmark offers a range of dermatological products for various skin conditions, including creams, gels, lotions, and ointments.
- Respiratory: Glenmark has been building a portfolio of respiratory products, including inhalers and other medications for asthma and chronic obstructive pulmonary disease (COPD).
- Cardiology: Glenmark manufactures a range of cardiovascular medications, including drugs for hypertension, lipid disorders, and heart-related conditions.
- Gastroenterology: Glenmark develops products for gastrointestinal disorders and offers medications for ulcers, acid reflux, and inflammatory bowel disease.
- Oncology: Glenmark has a growing presence in the field of oncology, with existing products offering a range of targeted therapies and supportive care medications for cancer treatment.
- Neurology: Glenmark provides neurological medications for epilepsy, Parkinson’s disease, and multiple sclerosis.
- Diabetes: Glenmark offers anti-diabetic medications, including oral hypoglycemic agents and insulin formulations, to help manage diabetes.
- Pain management: Glenmark manufactures analgesics and pain management medications for various pain forms, including musculoskeletal and neuropathic pain.
- Anti-infectives: Glenmark develops anti-infective medications, including antibiotics and antifungal agents, to treat various infections.
Glenmark Place Strategy
Glenmark Pharmaceuticals is an Indian company with an international presence. It serves a wide-spread global area and is headquartered in Mumbai, Maharashtra, India. It has seventeen manufacturing facilities in five countries, including India, the Czech Republic, Argentina, Switzerland, and the United States.
Glenmark’s active business of pharmaceutical ingredients is spread over eighty countries, including markets like Canada, Japan, Europe, and new markets in the United States. Most of its products are marketed in Western Europe and the United States.
It has established six highly efficient centers for product design and R&D equipped with the world’s latest technology. Manufacturing units for its formulation business are located at four centers in India, including Gujarat, Goa, Himachal Pradesh, and Maharashtra, and two in foreign soils, Brazil and the Czech Republic.
The company has an advanced distribution channel, including regional offices in nearly forty countries. It has a capable workforce that includes almost twelve thousand employees to help it in its efforts to provide better results. Glenmark’s consumer healthcare products are available at medical facilities and prescription stores.
Here are five points that highlight aspects of Glenmark’s distribution strategy:
- Global Presence: Glenmark has a strong international presence with subsidiaries, marketing and distribution networks, and manufacturing facilities across various regions, ensuring its products are accessible to patients and healthcare providers worldwide.
- Strategic Alliances: The company collaborates with strategic partners, including distributors and wholesalers, to reach healthcare markets efficiently. These alliances enable Glenmark to optimize its supply chain and ensure the timely availability of its pharmaceutical products.
- Multichannel Approach: Glenmark employs a multichannel distribution approach, which includes traditional pharmaceutical distribution channels, pharmacies, hospitals, and specialty healthcare providers. This approach allows the company to cater to diverse customer segments.
- Online and E-commerce: Glenmark recognizes the growing importance of e-commerce and digital channels in pharmaceutical distribution. It may utilize online platforms to reach consumers directly or collaborate with online pharmacies for distribution.
- Regulatory Compliance: Glenmark adheres to strict regulatory requirements in each market. This includes complying with Good Distribution Practices (GDP) and other relevant pharmaceutical regulations to ensure its products’ quality, safety, and integrity throughout the distribution process.
Glenmark Pricing Strategy
According to one analysis of the surveys, Glenmark’s revenues have been estimated at Rupees 5817.39 Crore and profits at Rs. 1468.43 Crore. Glenmark supposedly spends Rupees 290.86 crore on its R&D facilities. Glenmark Pharmaceuticals is a company that believes in operating in a healthy manner that is environmentally conscious, proactive, and ethical.
With changing scenarios in regional and global sectors, the company has tried to maintain a suitable pricing policy that will benefit every party, including itself, its investors, and customers. The company has adopted a reasonable pricing policy for its products as it wants them to have a greater reach. Moreover, it realizes that affordable and cost-rational prices will result in more significant sales volumes and better revenues.
Here is an overview of Glenmark’s pricing strategy:
- Value-Based Pricing: Glenmark bases its pricing decisions on the perceived value its pharmaceutical products offer to patients, healthcare providers, and payers. This approach involves assessing the therapeutic benefits, efficacy, safety profile, and uniqueness of its drugs compared to existing alternatives.
- Market Segmentation: Glenmark tailors its pricing strategies to different market segments and geographies. When setting prices, it considers factors such as local healthcare infrastructure, competition, and socioeconomic conditions.
- Competitive Positioning: Glenmark closely monitors its competitors’ pricing strategies and adjusts pricing to maintain a competitive advantage. This may involve pricing its products slightly below or at par with similar medications while highlighting the unique benefits of its offerings.
- Lifecycle Management: Glenmark carefully manages the pricing of its products throughout their lifecycle. Initial launch prices may be higher to recoup research and development costs, while prices may be adjusted as patents expire and generic competition emerges.
- Access Programs and Discounts: To enhance access to its medications, Glenmark may establish patient assistance programs and offer discounts to healthcare institutions, government agencies, and bulk purchasers. These initiatives help ensure that essential medicines are affordable and accessible to those in need.
Glenmark Promotion Strategy
Glenmark has constantly upgraded its marketing and advertising policies to maintain and maximize its brand visibility. It has received several accolades and awards for exceptional service and ground-breaking patents and innovations.
Glenmark has been part of several events to remain in the limelight and increase its brand awareness. The company has been a prominent donator during medical donation camps and has offered support and services through its workforce and products in hours of need.
Glenmark employs an integrated promotion and marketing strategy that includes targeted marketing campaigns to healthcare professionals, educational initiatives about its pharmaceutical products, and digital outreach to engage patients and raise awareness of its therapeutic offerings. Additionally, the company fosters partnerships with key opinion leaders and participates in medical conferences to reinforce its presence in the healthcare industry.
It is committed to ensuring conservation and resource efficiency and addressing climate change by providing willing help in reducing the intensity of carbon emissions and adopting practices, processes, and technologies for preventing pollution. Glenmark recognizes the effects and risks of climate change globally and has decided to adopt means for reducing environmental impacts.
Some Recent Video ads and Print ads of Glenmark are:
Liked this post? Check out the complete series on Marketing Mix
